The sudden death of Caroline Savage has raised questions about the use of Mounjaro, a weight-loss medication, and the potential risks associated with it. The 73-year-old woman died from faecal peritonitis, a rare condition caused by the perforation of the intestines, which may have been linked to her use of Mounjaro. The inquest into her death has revealed concerns about the hospital's response to her symptoms and the potential for doctors to have been too quick to attribute her condition to the drug, rather than investigate further.
Mounjaro, which is known to have gastrointestinal side effects, including abdominal pain and constipation, was prescribed to Caroline Savage to help her lose weight and manage symptoms associated with lipoedema and lymphoedema. She had been taking the medication for around four months and had increased her dose recently. However, her death has brought attention to the potential risks of the drug and the importance of thorough investigations into any adverse reactions.
The inquest heard that Caroline Savage developed acute abdominal pain on the morning of October 18, 2024, and was taken to the Norfolk and Norwich Hospital. Despite initial concerns about pancreatitis, her blood results did not indicate this condition, and she was discharged from the hospital hours before she collapsed and died at home. The post-mortem examination revealed that she died from faecal peritonitis, a condition that is not typically associated with Mounjaro, although possible links were discussed during the hearing.
The family of Caroline Savage has raised concerns about the hospital's response to her symptoms and the potential for doctors to have been too quick to attribute her condition to the drug, rather than investigate further. They have questioned the hospital's record-keeping and communication between clinicians, and argued that her symptoms should have prompted further investigation. The family's barrister submitted that Article 2 of the European Convention on Human Rights - the right to life - should be engaged because of potential systemic failures in communication, documentation, and clinical decision-making at the hospital.
The hospital has carried out a review of her care, and consultant Dr Hussain Hommad stated that her presentation, blood tests, observations, and ultrasound findings were all within normal limits at the time she was assessed. He added that diverticular perforation was extremely difficult to predict and that clinicians had acted appropriately based on the information available. The hospital's solicitor, Alison Brockhurst, argued that Caroline Savage's death was from natural causes and that the high threshold for engaging Article 2 had not been met.
The inquest is ongoing, and the coroner, Yvonne Blake, has adjourned the decision on whether Article 2 should apply. The case highlights the importance of thorough investigations into adverse reactions to medications and the potential risks associated with weight-loss drugs. It also raises questions about the responsibility of healthcare providers to ensure that patients receive appropriate care and that their symptoms are properly investigated.
